# Copper Peptide Hair Growth: GHK-Cu Follicle and Anagen Research

> Copper peptide hair growth research: a 45-man GHK combination trial, a 2024 microemulsion that reached anagen in 6 days, follicle and dermal-papilla findings, and the honest limits. GHK-Cu cited.

The strongest controlled human signal, the 2024 anagen result, the follicle and dermal-papilla data, and a clear marker where the evidence is preclinical or tests an analog rather than GHK-Cu itself.

## The copper peptide hair growth evidence, ranked by strength

Copper peptide hair growth research has one standout controlled human result and a deeper bench of preclinical and analog data behind it. The standout: in a 6-month trial of 45 men with androgenetic alopecia (Norwood-Hamilton II–V), a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide (ALAVAX) raised hair count by 52.6 at 100 mg/mL and 71.5 at 50 mg/mL, against 9.6 for placebo, with no adverse events in any group [4]. That is a real, statistically significant signal — and it tested a 5-ALA + GHK combination, not pure GHK-Cu, which is the single most important caveat on this page [4].

The mechanism underneath is non-androgenic. A 2026 review of short peptides for hair loss summarizes GHK-Cu as raising VEGF in dermal fibroblasts, stimulating microvascular angiogenesis and collagen/glycosaminoglycan synthesis, and promoting follicular extracellular-matrix turnover, citing the 45-patient trial as foundational [15]. The animal record reaches back further: peptide-copper complexes stimulated hair-follicle activity and growth in C3H mice, the early model that put copper peptides on the hair-research map [7]. This page keeps the human, animal and analog tiers separate so the [GHK-Cu research findings](/research) are never overstated.

## Does Copper Peptide Regrow Hair in the Research?

In the research, the clearest regrowth signal is the 45-man combination trial, where the ALAVAX 5-ALA + GHK complex raised hair count by 52.6 and 71.5 against 9.6 for placebo over 6 months, with no adverse events [4]. That is the strongest controlled human result for a GHK-containing topical — but it is a combination formulation, so it shows that a GHK-containing product regrew hair, not that GHK-Cu alone did [4]. Pure GHK-Cu monotherapy has no standalone controlled human efficacy trial.

Preclinical and analog work fills in around it. A 2024 ionic-liquid microemulsion delivering 2% GHK-Cu to mouse scalp drove follicles into the anagen growth phase within 6 days, versus 9 days for minoxidil, with higher hair density at 28 days and no change in testosterone or estradiol [14]. So in models, copper peptides do reactivate follicles — but the human regrowth evidence rests on one combination trial, and that distinction is the honest answer.

## Copper Tripeptide-1 for Hair: Follicle and Anagen Findings

Copper Tripeptide-1 for hair — the cosmetic name for GHK-Cu — shows its most mechanistically detailed effects in follicle-level models. The 2024 microemulsion study is the clearest: 2% GHK-Cu activated Wnt/beta-catenin signaling and upregulated VEGF and HGF on its way to driving mouse follicles into anagen in 6 days [14]. Wnt/beta-catenin is the canonical anagen-induction pathway, which places copper peptide's hair effect in a recognized growth mechanism rather than a vague "stimulation" claim [14].

At the cellular level, the closest direct evidence uses an analog and must be read as such. AHK-Cu, the alanyl analog of GHK-Cu, stimulated elongation of human hair follicles ex vivo and proliferation of dermal papilla cells in vitro at 10⁻¹² to 10⁻⁹ M, and at 10⁻⁹ M reduced apoptosis (a higher Bcl-2/Bax ratio, lower cleaved caspase-3 and PARP) [8]. This is anti-apoptotic, pro-proliferative follicle activity from a close copper-tripeptide cousin — strong supporting context, but it is AHK-Cu, not GHK-Cu, so it is cited as analog evidence and never as GHK-Cu efficacy [8].

## Frequently asked hair questions

Direct, sourced answers to the questions readers ask most about copper peptides and hair. Each keeps the human, animal and analog tiers in view.

---

The GHK-Cu copper-peptide record sorted into clean capsules — each hair, collagen and gene-expression finding paired with its source and its honest gap, with no clinic on the line and nothing here on a shelf.